Cost-Effectiveness Analysis of Nefecon versus Best Supportive Care for People with Immunoglobulin A Nephropathy (IgAN) in the United States

Ramjee, L; Vurgun, N; Ngai, C; Patel, M; Tremblay, G

Tremblay, G (通讯作者),Cytel Inc, 1050 Winter St 2700, Waltham, MA 02451 USA.

CLINICOECONOMICS AND OUTCOMES RESEARCH, 2023; 15 (): 213

Abstract

Purpose: To estimate the cost-effectiveness of Nefecon in addition to the best supportive care (BSC) vs BSC in a hypothetical cohort of commercially i......

Full Text Link